(Q44233496)

1 December 2017

Increased alpha 2-macroglobulin in diabetes: a hyperglycemia related phenomenon associated with reduced antithrombin III activity (English)

1 reference

1 December 2017

1 reference

1

1 reference

1 December 2017

D Giugliano

2

0 references

author name string

A Quatraro

3

1 reference

1 December 2017

A Stante

4

1 reference

1 December 2017

P Dello Russo

5

1 reference

1 December 2017

R Torella

6

1 reference

1 December 2017

1 April 1989

1 reference

Acta diabetologica latina

1 December 2017

1 reference

1 December 2017

26

1 reference

1 December 2017

2

1 reference

1 December 2017

147-154

1 reference

Preparation and Use of a Boronic Acid Affinity Support for Separation and Quantitation of Glycosylated Hemoglobins

1 December 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02581366

Alpha 2-macroglobulin and antithrombin-heparin cofactor: modulators of hemostatic and inflammatory reactions. Alpha 2-macroglobulin

21 January 2018

1 reference

12 December 2020

Induced Hyperglycemia Alters Antithrombin III Activity but not its Plasma Concentration in Healthy Normal Subjects

1 reference

12 December 2020

Non-enzymatic glycosylation reduces antithrombin III activity

1 reference

12 December 2020

Antithrombin 3 deficiency in maturity onset diabetes mellitus and atherosclerosis

1 reference

12 December 2020

Heparin preserves antithrombin III biological activity from hyperglycemia-induced alterations in insulin-dependent diabetics

1 reference

12 December 2020

Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation. Possible role in fibrin deposition in diabetes

1 reference

12 December 2020

Daily rapid blood glucose variations may condition antithrombin III biologic activity but not its plasma concentration in insulin-dependent diabetes. A possible role for labile non-enzymatic glycation.

1 reference

12 December 2020

Immunochemical quantitation of antigens by single radial immunodiffusion

1 reference

12 December 2020

Soluble fibrin complexes and fibrinogen heterogeneity in diabetes mellitus

1 reference

12 December 2020

Metabolic Control May Alter Antithrombin III Activity but Not Its Plasma Concentration in Diabetes: A Possible Role for Nonenzymatic Glycosylation

1 reference

12 December 2020

Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro

1 reference

12 December 2020

Determination of alpha-2-macroglobulin as trypsin-protein esterase

1 reference

12 December 2020

Decreased antithrombin III activity in diabetes may be due to non-enzymatic glycosylation--a preliminary report

1 reference

12 December 2020

Coagulation abnormalities in diabetic coma before and 24 hours after treatment

1 reference

12 December 2020

Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH).

1 reference

12 December 2020

alpha1-Macroglobulin and reduced basement-membrane degradation in diabetes

1 reference

12 December 2020

In vitro preparation of nonenzymatically glucosylated human transferrin, alpha 2-macroglobulin, and fibrinogen with preservation of function

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02581366

1 reference

1 December 2017

1 reference